Your search for major depressive disorder returned 250 results

Delay or lack of speech, seizures, and walking/balance disorders are some of the symptoms associated with AS.

Investigators aim to facilitate early recognition and consideration for patients with Duchenne muscular dystrophy and internalizing psychiatric symptoms.

Mirtazapine is a central alpha-2 antagonist currently FDA-approved for the treatment of major depressive disorder.

Investigators sought to determine the frequency of major depressive disorder in patients in epilepsy clinics.

Multimarker inflammatory biosignatures are expected to facilitate diagnosis and predict treatment outcomes for various central nervous system disorders, particularly Alzheimer disease and major depressive disorder.

A study evaluated the long-term adverse effects of maternal depression on child development.

Greater depressive symptoms are associated with episodic memory and markers of brain aging in older Caribbean Hispanic patients.

Lundbeck announced that the FDA has approved a sNDA for Trintellix to include data regarding improved processing speed.

Researchers sought to assess outcomes in hospitalized patients with comorbid Parkinson disease and major depressive disorder following administration of deep brain stimulation.

For patients with major depressive disorde, relapse is associated with brain cortical changes over two years.

For adults with bipolar depression, tDCS seems to be safe and effective as an add-on intervention.

The FDA has cleared Nexstim’s NBT system for the treatment of major depressive disorder.

Most patients undergoing skull base irradiation for cancer do not have detectable cognitive impairment.

Eli Lilly reports more positive phase 3 data for its acute migraine drug lasmiditan, while yet another brain-training company comes under fire for making baseless claims.

Escitalopram may be better for the treatment of depression than tDCS.

Prescriptions for benzodiazepine lasting 2-3 months or more and marked dose increases should be avoided.

Effectively treating pain may help improve cognitive and functional outcomes in patients with depression.

Migraine was more significantly associated with pain or muscle soreness than anxiety disorders in patients with depression.

Overall, 26 of the 34 studies suggested a positive relationship between insomnia and depression.

Time spent on mobile phones and social media may contribute to the rise in depression.

Patients with type 2 diabetes and major depressive disorder spent a significant amount of time experiencing depressive episodes.

Those suffering from depression and those diagnosed with temporal lobe epilepsy present with dysfunction across several cognitive domains.

HIV-infected adults with major depressive disorder have a 30% increased risk for acute myocardial infarction.

Results indicate that patients with AUD show significant impairments in social problem resolution task.

New findings suggest shared genetic etiology vs causal relationship in comorbid migraine and depression.

The odd relationship may have more to do with the mental disorder than the drugs.

Sixty percent of patients responded to treatment.

The drug was found to work quickly in patients with clinical major depression.

The device is used to condition the patient to reduce or stop their aggressive behavior.

Depression of some degree is prevalent in a majority of patients with ALS.